Rallybio Corp (RLYB) stock
RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)
Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –
Rallybio operating margin
Operating margin is operating income as a percentage of revenue.
Rallybio's operating margin for the twelve months ending Sep 30, 2026 was -5580.9%. For fiscal 2025 it was -3853.6%, against -9511.9% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3853.6% | +5658.3 |
| FY2024 | Dec 31, 2024 | -9511.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -4119.3% | +442.0 |
| Q4 FY2025 | Dec 31, 2025 | -2888.3% | +27659.1 |
| Q3 FY2025 | Sep 30, 2025 | -3266.5% | +768.9 |
| Q2 FY2025 | Jun 30, 2025 | -4743.9% | +953.5 |
| Q1 FY2025 | Mar 31, 2025 | -4561.3% | – |
| Q4 FY2024 | Dec 31, 2024 | -30547.4% | – |
| Q3 FY2024 | Sep 30, 2024 | -4035.5% | – |
| Q2 FY2024 | Jun 30, 2024 | -5697.3% | – |
See a number that looks wrong?